ArticleOncotarget2018

MiR-29b-1-5p is altered in BRCA1 mutant tumours and is a biomarker in basal-like breast cancer.

Michael J G Milevskiy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.